The modified IL-8 Luc assay, an in vitro skin sensitisation test, can significantly improve the false-negative judgment of lipophilic sensitizers with logKow values > 3.5

Arch Toxicol. 2021 Feb;95(2):749-758. doi: 10.1007/s00204-020-02934-9. Epub 2020 Oct 17.

Abstract

False-negative judgment due to poor chemical solubility is a problem with in vitro skin sensitisation tests. Water-insoluble chemicals are typically dissolved in DMSO in most sensitisation tests but precipitate when diluted with medium beyond their solubility in water. Such tests lack procedures to rule out false-negative judgments due to poor solubility. The IL-8 Luc assay (OECD442E) is unique in that if chemicals do not dissolve at 20 mg/mL in medium and have no effect on IL-8 luciferase activity (IL8LA), they are classified as indeterminate. The purpose of the present study was to reduce the number of indeterminate chemicals and improve assay performance. The IL-8 Luc assay can simultaneously examine glyceraldehyde 3-phosphate dehydrogenase luciferase activity (GAPLA) and IL8LA, and thus we examined the correlation between the reduction of GAPLA (defined as Inh-GAPLA) and the reduction of propidium iodide (PI)-excluding cells for three sensitizers and three non-sensitizers. We observed a significant correlation between luciferase activity driven by the GAPDH promoter of THP-G8 cells and the number of viable cells. Furthermore, chemicals providing an Inh-GAPLA value below 0.8 always reduced the ratio of PI-excluding cells to less than 0.6. Using the modified criteria, indeterminate chemicals are judged as negative if they provide Inh-GAPLA values below 0.8. This modification reduced the number of indeterminate chemicals and increased specificity, highlighting the unique advantage of the IL-8 Luc assay.

Keywords: Lipophilic chemicals; Luciferase assay; Reporter assay; Skin sensitisation test.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allergens / toxicity*
  • Animal Testing Alternatives / methods*
  • Biological Assay / methods*
  • Cell Line
  • Dermatitis, Allergic Contact*
  • False Negative Reactions
  • Gene Expression Regulation
  • Genes, Reporter
  • Glyceraldehyde-3-Phosphate Dehydrogenases / genetics
  • Humans
  • Interleukin-8 / genetics*
  • Luciferases / genetics*
  • Peptide Fragments / genetics
  • Promoter Regions, Genetic
  • Skin Tests / methods*
  • THP-1 Cells

Substances

  • Allergens
  • CXCL8 protein, human
  • Interleukin-8
  • Peptide Fragments
  • glyceraldehyde 3-phosphate dehydrogenase (304-313)
  • Luciferases
  • Glyceraldehyde-3-Phosphate Dehydrogenases